Ionis Pharmaceuticals IONS
NASDAQ IONS
$43.54 -0.46 (-1.05%)
At close: Oct 2, 2026 · 4:00 PM EDT

Ionis Pharmaceuticals (IONS) Return on Sales [ROS] (2009 - 2026)

Updated

Ionis Pharmaceuticals (IONS) recorded Return on Sales [ROS] of -38.18% in Q2 2026, down 69.11 percentage points from 30.93% a year earlier but up 9.54 percentage points from the prior quarter.

Analysis

Ionis Pharmaceuticals (IONS) Return on Sales [ROS] (2009 - 2026) Analysis & Trends

On a TTM basis, Ionis Pharmaceuticals' Return on Sales [ROS] came in at -68.00% as of Jun 30, 2026, down 39.77 percentage points year-over-year; for FY2025, it was -40.45%, up 26.93 percentage points from FY2024.

  • Annual Return on Sales [ROS] has a five-year change of -16.85 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Sales [ROS] came in at -67.37% in FY2024 (-22.46 pp), -44.91% in FY2023 (+24.93 pp), -69.84% in FY2022 (-66.11 pp) and -3.72% in FY2021 (+19.87 pp).
  • Quarterly Return on Sales [ROS] has ranged from -136.95% in Q4 2022 to 50.14% in Q4 2021 over the past five years.
  • On a year-over-year basis, Return on Sales [ROS] rose in four of the last eight quarters, with an average year-over-year change of -4.74 percentage points.
  • Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 135.07 percentage points in Q4 2023, against a drop of 187.09 percentage points in Q4 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at -47.72% (Q1 2026), -105.47% (Q4 2025) and -102.21% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 28.21%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 37.86%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 32.97%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 20.57%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 34.95%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -133.21%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 28.37%
10 Ionis Pharmaceuticals 7.21 Bn -1.68 Bn 265.21 Mn -38.18%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -38.18%
Mar 31, 2026 -47.72%
Dec 31, 2025 -105.47%
Sep 30, 2025 -102.21%
Jun 30, 2025 30.93%
Mar 31, 2025 -111.59%
Dec 31, 2024 -48.91%
Sep 30, 2024 -111.09%
Jun 30, 2024 -29.34%
Mar 31, 2024 -125.12%
Dec 31, 2023 -1.89%
Sep 30, 2023 -99.35%
Jun 30, 2023 -47.87%
Mar 31, 2023 -87.45%
Dec 31, 2022 -136.95%
Sep 30, 2022 -37.03%
Jun 30, 2022 -63.92%
Mar 31, 2022 -40.52%
Dec 31, 2021 50.14%
Sep 30, 2021 -64.50%
API Access

Ionis Pharmaceuticals Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=IONS&period=max&api_key=YOUR_API_KEY